Alzheimer’s disease is a devastating neurodegenerative disorder and the most common form of dementia. It’s marked by the ...

MRI scans can detect signs of the disease years earlier than PET scans, a recent study published in ‘Nature Neuroscience’ ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

Oshkosh’s Walk to End Alzheimer’s raised $55,000 for education, care and support services for families affected by the ...

The finding in human cerebrospinal fluid also raises the possibility of using meprin-β as an indicator of Alzheimer’s. This ...

Doctors treating early Alzheimer’s disease may eventually be able to learn more from a simple blood sample. A study from ...

Called PASCode and iBrainMap, and published recently in Nature Medicine and Nature Communications, respectively, the new ...

Cure Alzheimer’s Fund® (CureAlz®) today announced its second cohort of Cardinal Family Scholars who, combined, will receive a total of $6.4 mi ...

Alzheimer’s disease slowly damages memory, thinking and the ability to manage everyday life. One major sign of the disease is ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.